Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by HighteawithIntrepidon Jun 21, 2017 9:10pm
179 Views
Post# 26390455

RE:RE:RE:I wonder if the FDA is currently working on...

RE:RE:RE:I wonder if the FDA is currently working on...If we are skipping 6 months of review then the FDA should have
hinted that to PLI and the 1.70 share offering is one big FUBAR 
but given the corporations missed time lines I doubt it. 
As I said yesterday markets don't like to be left in the dark and
down was my call and down we are. The 1.70 boys will defend 1.71
so Thursday should be a very narrow 1.70-1.72. But some real news remains
the wild card and game changer.
Bullboard Posts